Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Patience #7

<< Previous

Bullboard Posts

Next >>

Post by BioTeckon Apr 04, 2022 3:31pm

220 Views

Post# 34574233

Patience #7

Patient 7 was identified many moons ago, I bet this person has not been implanted yet. Another reason why pharma isn't rushing to get in bed with Sernova, they know they have tons of time. Nothing but time. Makes you wonder what actually has been done this year? According to the share price, nothing. According to the press releases, nothing. I guess that explains why we are where we are.

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages